LDL Percent Reduction Needed Calculator
LDL Percent Reduction Needed Calculator
Work out the percentage LDL reduction between a current value and a target, and read it against the ACC/AHA statin intensity definitions to see which intensity is the sensible starting point.
LDL Percent Reduction Needed
2 inputs → % reductionCurrent LDL 160 mg/dL, target LDL 70 mg/dL
Formula
The result is unit-independent as long as both values use the same unit.
- current LDL
- the untreated value, or the value on current therapy if the question is what a change in therapy must achieve
- target LDL
- the goal set by absolute cardiovascular risk — commonly 100, 70 or 55 mg/dL (2.6, 1.8 or 1.4 mmol/L)
- %
- a proportion of the current value, so both terms cancel their units; mg/dL and mmol/L give the same percentage
Worked example
Current LDL 160 mg/dL, target LDL 70 mg/dL
Absolute gap = 160 − 70 = 90 mg/dL
90 ÷ 160 × 100 = 56.3%
Above 50% → high-intensity statin territory on the ACC/AHA definitions
The same pair in mmol/L (4.14 and 1.81) gives the same 56.3%
ACC/AHA statin intensity definitions
| Intensity | Average LDL reduction | Examples |
|---|---|---|
| High | ≥ 50% | Atorvastatin 40–80 mg, rosuvastatin 20–40 mg |
| Moderate | 30 – 49% | Atorvastatin 10–20 mg, rosuvastatin 5–10 mg, simvastatin 20–40 mg |
| Low | < 30% | Simvastatin 10 mg, pravastatin 10–20 mg |
Reduction needed for common current-and-target pairs
| Current LDL (mg/dL) | To 100 | To 70 | To 55 |
|---|---|---|---|
| 130 | 23.1% | 46.2% | 57.7% |
| 160 | 37.5% | 56.3% | 65.6% |
| 190 | 47.4% | 63.2% | 71.1% |
| 220 | 54.5% | 68.2% | 75.0% |
Choosing a starting intensity from the size of the gap
The arithmetic here is trivial and the interpretation is not. The percentage is the gap between the current LDL and the target expressed as a proportion of the current value, and it is unit-independent: a pair in mmol/L gives exactly the same percentage as the same pair in mg/dL. What the number is for is matching the size of the gap to a treatment intensity before starting, rather than titrating blindly and rechecking.
The ACC/AHA definitions give the anchors. High-intensity statin therapy lowers LDL by 50% or more on average, moderate-intensity by 30 to 49%, and low-intensity by less than 30%. Those are averages across trial populations, and individual response varies widely around them — some patients on a high-intensity statin achieve 30%, others 65%. The percentage therefore tells you which intensity to start with; it does not tell you what will happen. Recheck the lipid profile after six to twelve weeks and adjust against the measured response.
Where a gap cannot be closed by one drug, the shape of the dose-response matters. Roughly every doubling of a statin dose adds only about a further 6% LDL reduction — the so-called rule of six — so moving to a more efficacious statin achieves more than pushing the dose of a weaker one, and doubling again to close a 15% gap is rarely productive. Adding ezetimibe contributes around a further 20% on top of a statin, and a PCSK9 inhibitor around 50 to 60%, which is why gaps well beyond 50% are usually planned as combination therapy from the start.
Two results deserve care. A negative or zero percentage means the target is already met, and the useful question becomes whether the target matches the patient’s absolute risk — targets tighten in secondary prevention and in familial hypercholesterolaemia. And a percentage calculated from a single untreated LDL inherits that value’s uncertainty, including biological variation of roughly 8 to 10% between samples and whichever estimating equation the laboratory used. Confirm a decision-changing LDL on a repeat sample before committing to an intensity.
Frequently asked questions
How do I calculate the percentage LDL reduction needed?
Subtract the target from the current LDL, divide by the current LDL and multiply by 100. Because it is a proportion, the answer is the same whether both values are in mg/dL or mmol/L.
What counts as a high-intensity statin?
On the ACC/AHA definitions, therapy that lowers LDL cholesterol by 50% or more on average. Moderate-intensity therapy lowers it by 30 to 49%, and low-intensity by less than 30%.
Will doubling the statin dose close the gap?
Usually not by much. Each doubling of dose adds only about a further 6% LDL reduction, so switching to a more efficacious statin or adding a second agent achieves more than dose escalation alone.
How much do ezetimibe and PCSK9 inhibitors add?
Ezetimibe adds roughly a further 20% LDL reduction on top of a statin, and a PCSK9 inhibitor roughly 50 to 60%. Gaps of well over 50% are therefore usually planned as combination therapy.
What does a zero or negative result mean?
That the current LDL is already at or below the target, so no further reduction is needed to meet it. The remaining question is whether the target itself is right for the patient’s absolute cardiovascular risk.
Related calculators
References
- Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation. 2014;129(25 Suppl 2):S1–S45.
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC multisociety guideline on the management of blood cholesterol. Circulation. 2019;139(25):e1082–e1143.
- Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–1681.